Company Filing History:
Years Active: 2014
Title: Innovations of Andreas Irmer in Antiinfective and Antitumoral Compounds
Introduction
Andreas Irmer is a notable inventor based in Fuellinsdorf, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiinfective and antitumoral compounds. His work focuses on the isolation of unique compounds from tropical lianas, which have potential therapeutic applications.
Latest Patents
Irmer holds a patent for "Antiinfective and antitumoral compounds isolated from tropical lianas." This invention relates to naphthoquinone derivatives that are isolated from solid callus cultures of two species from the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. The patent outlines methods for the production of these compounds and their use as pharmaceuticals targeting infections and tumors. He has 1 patent to his name.
Career Highlights
Andreas Irmer is affiliated with the University of Würzburg, where he conducts research and collaborates with other scientists. His work has been instrumental in advancing the understanding of plant-derived compounds and their potential medical applications.
Collaborations
Irmer has worked alongside notable colleagues such as Gerhard Bringmann and Stefan Rüdenauer. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Andreas Irmer's contributions to the field of pharmaceuticals through his innovative research on antiinfective and antitumoral compounds highlight the importance of plant-based solutions in modern medicine. His work continues to inspire advancements in therapeutic applications.